Advertisement
The U.S. government does not have the legal authority to force drug companies to disclose prices in their TV ads

Court Rules Against Drug Price Disclosures in TV Ads

0
Judges said HHS exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare, Medicaid
Cardioprotective therapies

Cardioprotective Therapy Use Lower With Cancer History

0
Utilization rate of antiplatelet therapies and statins significantly lower for patients with cancer history
A total of 10

CDC: Deaths From Exposure to Heat-Related Conditions Identified

0
Total of 10,526 deaths identified during 2004 to 2018; rates up for men, older adults, AI/ANs
Outpatient azithromycin use is associated with an increased risk for cardiovascular and noncardiovascular mortality

CVD, Non-CVD Mortality Increased With Azithromycin Use

0
Cardiovascular death risk increased within five days of azithromycin exposure, but not at six to 10 days
Changes have been suggested for the newborn critical congenital heart disease screening algorithm

Changes Proposed for Newborn Congenital Heart Disease Screen

0
Oxygen saturation of at least 95 percent in both upper, lower extremities required to pass
Higher blood pressure during exercise and impaired blood pressure recovery after exercise in midlife may be markers of subclinical and clinical cardiovascular disease and mortality in later life

Midlife Blood Pressure During Exercise Predicts Later Heart Disease

0
Higher BP during exercise, delayed BP recovery after exercise tied to later hypertension, heart disease, death
In recently menopausal women using hormone treatment

Hormone Therapies Tied to Brain Changes in Menopausal Women

0
Circulating levels of pituitary-ovarian hormones linked to changes in WMH in menopausal women
Higher levels of stressful life events are associated with a higher risk for coronary heart disease among postmenopausal women with type 2 diabetes

Stressful Life Events May Up CHD Risk in Type 2 Diabetes

0
Findings for coronary heart disease risk seen in large study of postmenopausal women with T2DM
The U.S. Food and Drug Administration has withdrawn its emergency authorization for the use of chloroquine phosphate and hydroxychloroquine sulfate in the fight against COVID-19.

FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19

0
Agency now says the drugs should not be used outside of clinical trials
Patients with type 2 diabetes who develop obstructive sleep apnea are at higher risk for cardiovascular disease and other diabetes-related complications

Sleep Apnea in Patients With T2DM Ups Risk for Comorbidities

0
Patients with T2DM and OSA diagnosis at higher risk for cardiovascular, microvascular complications